Registration Dossier
Registration Dossier
Diss Factsheets
Use of this information is subject to copyright laws and may require the permission of the owner of the information, as described in the ECHA Legal Notice.
EC number: 211-662-7 | CAS number: 682-11-1
- Life Cycle description
- Uses advised against
- Endpoint summary
- Appearance / physical state / colour
- Melting point / freezing point
- Boiling point
- Density
- Particle size distribution (Granulometry)
- Vapour pressure
- Partition coefficient
- Water solubility
- Solubility in organic solvents / fat solubility
- Surface tension
- Flash point
- Auto flammability
- Flammability
- Explosiveness
- Oxidising properties
- Oxidation reduction potential
- Stability in organic solvents and identity of relevant degradation products
- Storage stability and reactivity towards container material
- Stability: thermal, sunlight, metals
- pH
- Dissociation constant
- Viscosity
- Additional physico-chemical information
- Additional physico-chemical properties of nanomaterials
- Nanomaterial agglomeration / aggregation
- Nanomaterial crystalline phase
- Nanomaterial crystallite and grain size
- Nanomaterial aspect ratio / shape
- Nanomaterial specific surface area
- Nanomaterial Zeta potential
- Nanomaterial surface chemistry
- Nanomaterial dustiness
- Nanomaterial porosity
- Nanomaterial pour density
- Nanomaterial photocatalytic activity
- Nanomaterial radical formation potential
- Nanomaterial catalytic activity
- Endpoint summary
- Stability
- Biodegradation
- Bioaccumulation
- Transport and distribution
- Environmental data
- Additional information on environmental fate and behaviour
- Ecotoxicological Summary
- Aquatic toxicity
- Endpoint summary
- Short-term toxicity to fish
- Long-term toxicity to fish
- Short-term toxicity to aquatic invertebrates
- Long-term toxicity to aquatic invertebrates
- Toxicity to aquatic algae and cyanobacteria
- Toxicity to aquatic plants other than algae
- Toxicity to microorganisms
- Endocrine disrupter testing in aquatic vertebrates – in vivo
- Toxicity to other aquatic organisms
- Sediment toxicity
- Terrestrial toxicity
- Biological effects monitoring
- Biotransformation and kinetics
- Additional ecotoxological information
- Toxicological Summary
- Toxicokinetics, metabolism and distribution
- Acute Toxicity
- Irritation / corrosion
- Sensitisation
- Repeated dose toxicity
- Genetic toxicity
- Carcinogenicity
- Toxicity to reproduction
- Specific investigations
- Exposure related observations in humans
- Toxic effects on livestock and pets
- Additional toxicological data

Endpoint summary
Administrative data
Link to relevant study record(s)
Description of key information
No specific studies are available however based on physicochemical data, toxicity data and theoretical assessment, the basic toxicokinetics of 2-allyloxymethyl-2-ethylpropanediol can be adequately characterised. The substance is likely to be rapidly and extensively absorbed following oral or inhalation exposure, absorption following dermal exposure is likely to be less extensive and more gradual. Rapid and extensive distribution is predicted. Extensive hepatic metabolism of the substance is predicted, indicating that excretion is rapid and bioaccumulation is unlikely.
Key value for chemical safety assessment
- Bioaccumulation potential:
- no bioaccumulation potential
- Absorption rate - oral (%):
- 50
- Absorption rate - dermal (%):
- 50
- Absorption rate - inhalation (%):
- 100
Additional information
No specific studies are required. According to Column 1 of Annex VIII of the REACH regulation, assessment of the toxicokinetic behaviour of the substance (to the extent that can be derived from the relevant available information) is required and this is provided. An adequate assessment of the basic toxicokinetics of the substance can be made from the existing toxicity data and theoretical considerations, without the need for specific testing.
Absorption
The oral absorption of 2 -allyloxymethyl-2 -ethylpropanediol is predicted to be extensive on the basis of its low molecular weight, moderate Log Pow value and water solubility. Bioavailability is also predicted based on Lipinski’s Rule of Five (OECD QSAR Toolbox). An acute oral toxicity (McNerney, 1961) reports mortality in rats administered 2 -allyloxymethyl-2 -ethylpropanediol at very high dose levels of 3980, 7950 and 15800 mg/kg bw; a slight narcotic effect was noted consistent with systemic exposure. A 28-day oral (gavage) toxicity study (Karolinska Institutet, 2010) reports mild signs of systemic toxicity at 200 mg/kg bw/d; no additional treatment-related findings were observed in this study. A range-finder for this study is stated to have shown marked signs of toxicity following repeated gavage dosing at a dose level of 1000 mg/kg bw/d. An assumption of 50% oral absorption may be made for the purposes of risk assessment, according to REACH guidance.
The dermal absorption of 2 -allyloxymethyl-2 -ethylpropanediol is favoured by its relatively low molecular weight, moderate Log Pow value and water solubility. The very low vapour pressure of 2 -allyloxymethyl-2 -ethylpropanediol means that any substance coming into contact with the skin is unlikely to be lost through volatilisation. Dermal absorption is therefore predicted, but is likely to be less rapid and more extensive than oral absorption. In the absence of any specific data, an assumption of 50% dermal absorption may be made for the purposes of risk assessment, according to REACH guidance and on the basis that dermal absorption will not exceed oral absorption.
2 -allyloxymethyl-2 -ethylpropanediol is of very low volatility, therefore inhalation exposure is not predicted unless the substance is used in situations in which liquid aerosols may be generated (e.g. by spraying). If inhalation exposure were to occur, absorption is potentially extensive. A default assumption of 100% inhalation absorption may be made, if required, for the purposes of risk assessment.
Distribution
Based on its high water solubility, the systemic distribution of absorbed 2 -allyloxymethyl-2 -ethylpropanediol is likely to be rapid and extensive following oral, dermal or inhalation exposure.
Metabolism
OECD QSAR Toolbox predicts a total of 25 hepatic metabolites, including those generated though sequential oxidation of the alcohol groups and hydrolysis of the ether linkage. Three oxidative skin metabolites are also predicted; therefore a degree of metabolism may occur prior to systemic absorption following dermal exposure.
Excretion
The high water solubility and low molecular weight of 2 -allyloxymethyl-2 -ethylpropanediol and its metabolites indicate rapid urinary excretion. The predicted metabolism of the substance and its log Pow value indicate that bioaccumulation is unlikely.Information on Registered Substances comes from registration dossiers which have been assigned a registration number. The assignment of a registration number does however not guarantee that the information in the dossier is correct or that the dossier is compliant with Regulation (EC) No 1907/2006 (the REACH Regulation). This information has not been reviewed or verified by the Agency or any other authority. The content is subject to change without prior notice.
Reproduction or further distribution of this information may be subject to copyright protection. Use of the information without obtaining the permission from the owner(s) of the respective information might violate the rights of the owner.
